Snowflake Score | |
---|---|
Valuation | 1/6 |
Future Growth | 0/6 |
Past Performance | 4/6 |
Financial Health | 6/6 |
Dividends | 0/6 |
Zhejiang Runyang New Material Technology Co., Ltd. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | CN¥14.40 |
52 Week High | CN¥22.39 |
52 Week Low | CN¥9.81 |
Beta | 0.61 |
1 Month Change | -1.50% |
3 Month Change | -23.73% |
1 Year Change | -8.80% |
3 Year Change | -60.53% |
5 Year Change | n/a |
Change since IPO | -67.90% |
Recent News & Updates
Be Wary Of Zhejiang Runyang New Material Technology (SZSE:300920) And Its Returns On Capital
Apr 23Zhejiang Runyang New Material Technology Co., Ltd. (SZSE:300920) Investors Are Less Pessimistic Than Expected
Mar 06Shareholder Returns
300920 | CN Chemicals | CN Market | |
---|---|---|---|
7D | 9.3% | 1.7% | 1.6% |
1Y | -8.8% | -20.4% | -15.1% |
Return vs Industry: 300920 exceeded the CN Chemicals industry which returned -20.4% over the past year.
Return vs Market: 300920 exceeded the CN Market which returned -15.1% over the past year.
Price Volatility
300920 volatility | |
---|---|
300920 Average Weekly Movement | 15.2% |
Chemicals Industry Average Movement | 8.8% |
Market Average Movement | 8.8% |
10% most volatile stocks in CN Market | 12.6% |
10% least volatile stocks in CN Market | 5.3% |
Stable Share Price: 300920's share price has been volatile over the past 3 months.
Volatility Over Time: 300920's weekly volatility has increased from 8% to 15% over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2012 | 657 | n/a | www.zj-runyang.com |
Zhejiang Runyang New Material Technology Co., Ltd. engages in the research and development, production, and sale of polyolefin foam materials in China and internationally. It offers electron irradiation cross-linked polyethylene (IXPE), including antibacterial enhanced series, popular series, and special series.
Zhejiang Runyang New Material Technology Co., Ltd. Fundamentals Summary
300920 fundamental statistics | |
---|---|
Market cap | CN¥1.47b |
Earnings (TTM) | CN¥42.05m |
Revenue (TTM) | CN¥359.26m |
34.2x
P/E Ratio4.0x
P/S RatioIs 300920 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
300920 income statement (TTM) | |
---|---|
Revenue | CN¥359.26m |
Cost of Revenue | CN¥272.75m |
Gross Profit | CN¥86.52m |
Other Expenses | CN¥44.46m |
Earnings | CN¥42.05m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
Apr 25, 2024
Earnings per share (EPS) | 0.42 |
Gross Margin | 24.08% |
Net Profit Margin | 11.71% |
Debt/Equity Ratio | 1.3% |
How did 300920 perform over the long term?
See historical performance and comparison